Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances Using Camelina Platform to Produce PHA Biopl...
June 16 2021 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience
company, today announced that its Chief Science Officer Dr. Kristi
Snell will present during the 2021 Synthetic Biology: Engineering,
Evolution & Design (SEED) conference, taking place in a virtual
format June 15 through June 18, 2021.
Dr. Snell will present at the conference on
Wednesday, June 16 at 10:55 am PDT (1:55 pm EDT) during Session 4:
Synthetic Biology for Agriculture, Food and Personal Care. Her
presentation, entitled “Breakthroughs in Plant Based PHB
Production,” will describe how Yield10 researchers programmed
prototype plants with microbial genes based on a patent filed for
new technology developed to produce Camelina seed containing high
levels of PHA bioplastic suitable for field production.
In 2020, several Camelina lines were grown in small plots at
field test sites in the U.S. and Canada. Compared to control
plants, the engineered PHA Camelina lines emerged and matured
later, but once established exhibited good vigor, branching,
flowering and seed set. The results showed that the levels of PHA
produced in seed measured up to 6 percent PHA of mature seed weight
depending on the plant line tested, demonstrating proof-of-concept
for field production of PHA in Camelina sativa using the new
technology.
“These results mark a significant step towards commercial
production of PHA in plants, enabling a direct link between
low-cost large scale agricultural production of this exciting
biodegradable plastic, and the single use packaging and foodservice
segment of the 350 million ton per year global plastics market,”
said Kristi Snell, Ph.D., Chief Science Officer of Yield10
Bioscience. “We are continuing to work to make improvements to
the technology to bring the PHA levels up to the 10-20% range and
remain on track for seed scale up in the 2021 and 2022 growing
seasons to produce meaningful quantities of PHA, oil and meal for
customer sampling.”
PHAs are natural polymers, prevalent in nature and fully
biodegradable in the environment. Currently produced by
fermentation of engineered microbes, PHA polymers have commercial
applications as bioplastics to replace petroleum resins, in water
treatment where they act as a zero-waste solution to nitrate
pollution, as well as in animal feed ingredients. Yield10 has a
long history with and deep knowledge of PHA bioplastics and
believes that direct production of PHA in seed as a co-product with
oil and protein meal will enable low-cost commodity scale
production. By eliminating the feedstock inefficiency, capital, and
operating costs inherent in fermentation processes, the direct
production in Camelina seed has the potential to enable
commercialization of PHA bioplastics on an agricultural scale at
costs in line with commodity vegetable oils. This process would
ultimately support Yield10’s vision of driving large-scale adoption
in the plastics markets to manufacture a wide range of fully
biodegradable consumer products.
Learn more about the 2021 Synthetic Biology: Engineering,
Evolution & Design (SEED) conference on the conference website.
On June 16, a copy of Dr. Snell’s slide deck will be available on
the Yield10 Bioscience investor relations website.
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company
that is using its differentiated trait gene discovery platform, the
“Trait Factory”, to develop improved Camelina varieties to produce
proprietary seed products, and to discover high value genetic
traits for the agriculture and food industries. Our goals are to
efficiently establish a high value seed products business based on
developing superior varieties of Camelina to produce feedstock
oils, nutritional oils, and PHA bioplastics, and to license our
yield traits to major seed companies for commercialization in major
row crops, including corn, soybean, and canola. Yield10 is
headquartered in Woburn, MA and has an Oilseeds Center of
Excellence in Saskatoon, Canada.
For more information about the company, please visit
www.yield10bio.com, or follow the Company on Twitter, Facebook and
LinkedIn.
(YTEN-G)
Safe Harbor for
Forward-Looking Statements
This press release contains forward-looking statements which are
made pursuant to the safe harbor provisions of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. The forward-looking
statements in this release do not constitute guarantees of future
performance. Investors are cautioned that statements in this press
release which are not strictly historical, including, without
limitation, that the results of PHA levels in Camelina plants mark
a significant step towards commercial production of PHA in plants
and enable a direct link between low-cost large scale agricultural
production and the packaging and foodservice segment; that direct
production of PHA in seed as a co-product with oil and protein meal
has the potential to enable commercialization of PHA bioplastics on
an agricultural scale at costs in line with commodity vegetable
oils; that production and commercialization of PHA bioplastics
would support Yield10’s vision of driving large-scale adoption in
the plastics markets; and that PHA bioplastics could ultimately be
used to manufacture a wide range of fully biodegradable consumer
products, constitute forward-looking statements.
Such forward-looking statements are subject to a number of risks
and uncertainties that could cause actual results to differ
materially from those anticipated, including the risks and
uncertainties detailed in Yield10 Bioscience's filings with the
Securities and Exchange Commission. Yield10 assumes no obligation
to update any forward-looking information contained in this press
release or with respect to the matters described herein.
Contacts: Yield10 Bioscience:Lynne H. Brum,
(617) 682-4693, LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561) 479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024